Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.

Ruiz, Victor H; Shen, Yuwei; Abouelhassan, Yasmeen; Fouad, Aliaa; Nicolau, David P; Kuti, Joseph L

Ruiz, Victor H; Shen, Yuwei; Abouelhassan, Yasmeen; Fouad, Aliaa; Nicolau, David P; Kuti, Joseph L.

Afiliación

Ruiz VH; Center for Anti-infective Research and Development, Hartford Hospital, Hartford, CT, USA.
Shen Y; Center for Anti-infective Research and Development, Hartford Hospital, Hartford, CT, USA.
Abouelhassan Y; Center for Anti-infective Research and Development, Hartford Hospital, Hartford, CT, USA.
Fouad A; Center for Anti-infective Research and Development, Hartford Hospital, Hartford, CT, USA.
Nicolau DP; Center for Anti-infective Research and Development, Hartford Hospital, Hartford, CT.
Kuti JL; Department of Infectious Diseases, Hartford Hospital, Hartford, CT, USA.

Am J Health Syst Pharm ; 81(1): e21-e29, 2024 Jan 01.

Article en En | MEDLINE | ID: mdl-37740370

Asunto(s)

Cloruro de Sodio; Sulbactam; Humanos; Infusiones Intravenosas; Antibacterianos; Incompatibilidad de Medicamentos

Palabras clave

Acinetobacter baumannii; Y-site; compatibility; durlobactam; prolonged infusion; turbidity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cloruro de Sodio / Sulbactam Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Am J Health Syst Pharm Asunto de la revista: FARMACIA / HOSPITAIS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google